| Item Type | Name |
|
Academic Article
|
Visual genome-wide RNAi screening to identify human host factors required for Trypanosoma cruzi infection.
|
|
Academic Article
|
Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.
|
|
Academic Article
|
Potential use of synthetic a-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease.
|
|
Academic Article
|
A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.
|
|
Academic Article
|
Molecular characterization of Trypanosoma cruzi SAP proteins with host-cell lysosome exocytosis-inducing activity required for parasite invasion.
|
|
Academic Article
|
Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of a-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease.
|
|
Academic Article
|
A prophylactic a-Gal-based glycovaccine effectively protects against murine acute Chagas disease.
|
|
Academic Article
|
A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
|
|
Academic Article
|
The surface coat of the mammal-dwelling infective trypomastigote stage of Trypanosoma cruzi is formed by highly diverse immunogenic mucins.
|
|
Academic Article
|
Trypanosoma cruzi oleate desaturase: molecular characterization and comparative analysis in other trypanosomatids.
|
|
Academic Article
|
Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up.
|
|
Academic Article
|
Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi.
|
|
Academic Article
|
Trypanosoma cruzi: involvement of glycoinositolphospholipids in the attachment to the luminal midgut surface of Rhodnius prolixus.
|
|
Academic Article
|
Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine.
|
|
Academic Article
|
Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response.
|
|
Concept
|
Chagas Disease
|
|
Academic Article
|
Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease.
|
|
Academic Article
|
Diversity of anti-haemostatic proteins in the salivary glands of Rhodnius species transmitters of Chagas disease in the greater Amazon.
|
|
Academic Article
|
Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease.
|
|
Academic Article
|
Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting.
|
|
Academic Article
|
Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.
|
|
Academic Article
|
Synthesis of Gala(1,3)Gal?(1,4)GlcNAca-, Gal?(1,4)GlcNAca- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease.
|
|
Academic Article
|
Virus-like Particle Display of the a-Gal Epitope for the Diagnostic Assessment of Chagas Disease.
|
|
Academic Article
|
Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
|
|
Academic Article
|
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus.
|
|
Academic Article
|
Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease.
|
|
Academic Article
|
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
|
|
Academic Article
|
Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy.
|
|
Academic Article
|
New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia.
|
|
Academic Article
|
Specific Recognition of ?-Galactofuranose-Containing Glycans of Synthetic Neoglycoproteins by Sera of Chronic Chagas Disease Patients.
|
|
Academic Article
|
A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease.
|
|
Academic Article
|
Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
|
|
Academic Article
|
Fatty acid elongases 1-3 have distinct roles in mitochondrial function, growth, and lipid homeostasis in Trypanosoma cruzi.
|